Overview of Lung Degeneration
Chronic conditions that affect respiration severely shorten the life span of an individual by accelerating lung degeneration. Chronic Obstructive Pulmonary Disease (COPD) is among the most serious conditions, as it presents with the continual narrowing of airways and the resultant limitation of air flow. In addition to the respiratory challenges faced by patients, COPD is also characterized by the constant threat of the individual being oxygen deprived; this causes the illness to affect even the most basic of everyday activities. Where most of the medical community has focused on symptom management, the nature of lung degeneration has led others to implement therapies that can halt cell degeneration. To combat the challenges posed by lung degeneration and the respiratory conditions it causes, the Best Stem Cell Clinic offers pioneering treatment options based on the model of UC-MSCs.
Fundamental Biological Processes
In order to understand the restorative potential of UC-MSCs for COPD at the Best Stem Cell Clinic, the complex cellular activities brought about in response to the therapy must be understood. UC-MSCs, when injected into the lungs, establish an extensive paracrine signaling network. This leads to a release of cytokine secretomes (which include growth factors and cytokines) to the microenvironment of the lung that are inflamed and/or damaged. These secretomes can alter the systemic immune response and lead to a localized reduction of inflammation, assist in the clearing of cell debris, and even shift the phenotype of macrophages from the pro-inflammatory to the anti-inflammatory variant. These transformations further the healing of macrophages by inducing the proliferation of epithelial cells. The healing of the lungs is further augmented by the restoration of the lung matrix by the alveolar repair process. This treatment modifies the hostile fibrotic environment using its own cellular components to create a microenvironment that is much more amenable to tissue repair.
Limitations of Traditional Treatments
Current treatment options for Chronic Obstructive Pulmonary Disease (COPD) are agonizingly dependent on the use of bronchodilators in conjunction with inhaled corticosteroids. These traditional methods aim to relax the airway muscles under agonizing pain to reduce the frequency of acute exacerbation. Medical management often incorporates the use of supplemental oxygen as the stages of respiratory failure worsen. The primary limitation of these treatment options is that they do not have the ability to reverse the damage to the delicate pulmonary architecture. Slowly but surely the pharmacological therapies provide diminishing returns. The long-term side effects (of high dose corticosteroids) are severe and not easily treatable including the loss of bone density and systemic immunosuppression. After a maximum medical therapy has been implemented lung transplantation becomes the last resort. Care for the transplanted organ comes with severe risks such as organ rejection and a lifetime dependency on toxic immunosuppressant therapies. Because of these reasons, the Best Stem Cell Clinic utilizes UC-MSCs to provide a comprehensive approach to the repair of the pulmonary alveoli.
Rationale for Increase in Cellular Interventions
The basis for the adoption of the more advanced cellular replacement strategies at the Best Stem Cell Clinic is a movement from the medication of a patient to the biological reconstruction of a patient; for this the use of umbilical cord mesenchymal stem cells (UC-MSCs) to reverse chronic pulmonary airway inflammation which is a condition of COPD is both justified and needed. Living therapies do not function as synthetic pharmacotherapies where their function is primarily based on the blocking of a single faulty biological pathway; rather they are adaptive therapies that dynamically and comprehensively engage the inflammatory profiles particular to the site of tissue injury. Once the UC-MSCs home to the damaged alveoli they will elicit a healing response for the oxidation of tissues and will stop the progression of fibrosis.
Opting for targeted bio-restoration at the Best Stem Cell Clinic means that COPD patients are undergoing procedures that follow international safety guidelines. These patients are given UC-MSCs to help restore the respiratory tissues, which increases the capacity of the lungs.
Figure 1: Limitations of Traditional Treatments and Rationale for Increase in Cellular Interventions
Therapeutic Trends in Thailand
Thailand hosts the Best Stem Cell Clinic in Southeast Asia. The pathways to stem cell therapy are open because of the advanced regulations allied with the development of laboratory facilities. Thailand is at the forefront of integrating new techniques in research, most notably the use of umbilical cord mesenchymal stem cells (UC-MSCs). Along with the development of therapies, the cost of the services is comparatively low, making it one of the best options for foreign patients needing advanced respiratory therapies. With their geographical location allied with the superior research methodology in the stabilization of therapeutic agents and Controlled Therapeutic Agents, Thailand established itself as a leader in research in the reversal of progressive respiratory ailments (COPD and others).
Overall Conclusion
Pulmonary conditions are degenerative and progressive. UC-MSCs integrated in a therapeutic plan can help regenerate tissue. It can go beyond the limitations of traditional pharmacology. Advances in technology can provide the tools to restore a person’s respiratory system. For patients experiencing critical breathing limitations, the restoration of physical autonomy is now possible. Those diagnosed with COPD can visit the Best Stem Cell Clinic to receive cutting-edge cellular therapy to change the course of disease progression. The future of regenerative medicine persists in its commitment to the creation of new biotherapies to promote healing and create a positive, life-altering impact.